Alison Stribling
A5033535284- Smoking Behavior and Cessation
- Health, psychology, and well-being
- Health Policy Implementation Science
- Health Systems, Economic Evaluations, Quality of Life
- Advanced Neuroimaging Techniques and Applications
- Health and Wellbeing Research
- Functional Brain Connectivity Studies
- Obesity, Physical Activity, Diet
- Ethics in Clinical Research
- Advanced MRI Techniques and Applications
- Health disparities and outcomes
Cambridgeshire and Peterborough NHS Foundation Trust
2018-2019
Significance Adolescence is a period of human brain growth and high incidence mental health disorders. Here, we show consistently in two MRI cohorts that changes adolescence were concentrated on the more densely connected hubs connectome (i.e., association cortical regions mediated efficient connectivity throughout structural network). Hubs less myelinated at 14 y but had faster rates myelination shrinkage 14- to 24-y period. This topologically focused process consolidation was associated...
People with severe mental illnesses such as schizophrenia are three times more likely to smoke than the wider population, contributing widening health inequalities. Smoking remains largest modifiable risk factor for this inequality, but people illness have not historically engaged smoking cessation services. We aimed test effectiveness of a combined behavioural and pharmacological intervention targeted specifically at illness.In (SCIMITAR+) trial, pragmatic, randomised controlled study, we...
Randomised controlled trials (RCT) can struggle to recruit target on time. This is especially the case with hard reach populations such as those severe mental ill health. The SCIMITAR+ trial, a trial of bespoke smoking cessation intervention for people health achieved their recruitment ahead time and target. article reports strategies that helped us achieve this aim aiding others recruiting from similar populations. multi-centre pragmatic two-arm parallel-group RCT, which aimed 400...
Background There is a high prevalence of smoking among people with severe mental ill health (SMI). Helping SMI to quit could improve their and longevity, reduce inequalities. However, those are less likely access engage routine cessation services than the general population. Objectives To compare clinical effectiveness cost-effectiveness bespoke (BSC) intervention usual stop for SMI. Design A pragmatic, two-arm, individually randomised controlled trial. Setting Primary care secondary in...
Aims and method The SCIMITAR+ trial was commissioned to evaluate the effectiveness of a bespoke smoking cessation intervention for people with severe mental ill health compared usual services. It is difficult define what constitutes care in We aimed this during trial. Twenty-two National Health Service healthcare providers participated survey asking about their area. Results All sites offered support; however, service provider type varied substantially. In some cases services were not...